Prevalence of anti-AAV8 neutralizing antibodies and ARSB cross-reactive immunologic material in MPS VI patient candidates for a gene therapy trial | AVESİS

Hacettepe University Research Information System

Prevalence of anti-AAV8 neutralizing antibodies and ARSB cross-reactive immunologic material in MPS VI patient candidates for a gene therapy trial

Copy For Citation

Ferla R., Claudiani P., Savarese M., Kozarsky K., Hopwood J., Van der Ploeg A., ...More

ESGCT and NVGCT Collaborative Congress, The Hague, Netherlands, 23 - 26 October 2014, vol.25

Publication Type: Conference Paper / Summary Text
Volume: 25
City: The Hague
Country: Netherlands
Hacettepe University Affiliated: Yes